Keith M. Sullivan
#118,515
Most Influential Person Now
Researcher
Keith M. Sullivan's AcademicInfluence.com Rankings
Keith M. Sullivancomputer-science Degrees
Computer Science
#4698
World Rank
#4959
Historical Rank
Computational Linguistics
#505
World Rank
#513
Historical Rank
Machine Learning
#1009
World Rank
#1024
Historical Rank
Artificial Intelligence
#1232
World Rank
#1254
Historical Rank
Download Badge
Computer Science
Keith M. Sullivan's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Keith M. Sullivan Influential?
(Suggest an Edit or Addition)Keith M. Sullivan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. (1980) (2406)
- Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. (1981) (1132)
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. (1981) (883)
- Chronic graft-versus-host disease and other late complications of bone marrow transplantation. (1991) (738)
- Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (1999) (632)
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. (1989) (629)
- Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. (1998) (625)
- Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. (1983) (422)
- Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. (1989) (394)
- Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. (1997) (392)
- Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. (1990) (378)
- Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. (1996) (375)
- Bone marrow transplantation for sickle cell disease. (1996) (372)
- Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. (1989) (362)
- Infection with varicella-zoster virus after marrow transplantation. (1985) (355)
- Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. (1997) (350)
- Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. (2000) (348)
- Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma (2018) (344)
- Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. (1997) (326)
- New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (2000) (314)
- ASSOCIATION BETWEEN CYCLOSPORIN NEUROTOXICITY AND HYPOMAGNESAEMIA (1984) (308)
- Ovarian function following marrow transplantation for aplastic anemia or leukemia. (1988) (307)
- Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. (1983) (295)
- Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. (2001) (295)
- Intestinal and hepatic complications of human bone marrow transplantation. Part I. (1986) (289)
- Chronic cutaneous graft-versus-host disease in man. (1978) (286)
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. (1988) (279)
- Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. (1993) (259)
- Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. (2001) (257)
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. (2003) (257)
- Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. (1987) (257)
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation (1988) (251)
- High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. (2007) (247)
- Unrelated donor marrow transplantation in children. (1995) (246)
- Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. (1989) (242)
- Growth and development following marrow transplantation for leukemia. (1986) (229)
- Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts (1997) (227)
- Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan (2004) (224)
- Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. (2014) (215)
- High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. (2003) (211)
- Course of Crohn's disease after allogeneic marrow transplantation. (1998) (211)
- MARROW TRANSPLANTATION FOR THALASSAEMIA (1982) (205)
- Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. (1988) (201)
- Pathophysiology and treatment of graft-versus-host disease. (1999) (197)
- Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. (1984) (197)
- Risk factors for airflow obstruction in recipients of bone marrow transplants. (1987) (193)
- Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment (1981) (193)
- Analysis of late infections in 89 long-term survivors of bone marrow transplantation. (1979) (188)
- Long-term outcome after marrow transplantation for severe aplastic anemia. (1998) (186)
- Marrow harvesting from normal donors. (1984) (182)
- SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1 (2001) (182)
- Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. (2007) (182)
- Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. (1990) (176)
- Barriers to bone marrow transplantation for sickle cell anemia. (1996) (171)
- Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research (2007) (166)
- High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. (2002) (166)
- Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients (1982) (164)
- Factors associated with graft rejection after HLA‐identical marrow transplantation for aplastic anaemia (1983) (163)
- Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. (2010) (161)
- Oral manifestations of chronic graft-v-host disease. (1984) (158)
- Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. (1997) (157)
- Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10‐year follow‐up (1999) (156)
- Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. (2001) (156)
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. (2014) (156)
- Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. (1986) (155)
- Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. (1983) (154)
- Acute and chronic graft-versus-host disease in man. (1986) (152)
- Bone marrow transplantation in patients aged 45 years and older. (1986) (148)
- FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. (1996) (146)
- Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. (1982) (144)
- Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. (2001) (141)
- Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. (1986) (140)
- Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. (1981) (139)
- Case-Based Reasoning in CARE-PARTNER: Gathering Evidence for Evidence-Based Medical Practice (1998) (138)
- Cirrhosis of the liver in long-term marrow transplant survivors. (1999) (133)
- Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. (1995) (132)
- Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. (1997) (130)
- Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. (1981) (130)
- A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. (1996) (129)
- Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse (1983) (125)
- Late complications after marrow transplantation. (1984) (125)
- Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. (1984) (125)
- Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. (1989) (124)
- Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. (1981) (121)
- Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. (1992) (120)
- Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS‐related acute myeloid leukaemia (1996) (117)
- Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts (2018) (114)
- Late complications of allogeneic and autologous marrow transplantation. (1992) (113)
- Chronic graft-versus-host disease. (2006) (111)
- Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. (1987) (111)
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. (2019) (110)
- Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect. (1990) (108)
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. (1988) (107)
- Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. (1996) (106)
- Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. (2001) (104)
- Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. (1987) (103)
- Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial (1989) (102)
- What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants ? (1990) (102)
- Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. (1995) (100)
- Secondary failure of platelet recovery after hematopoietic stem cell transplantation. (2001) (100)
- Polymyositis as a manifestation of chronic graft-versus-host disease. (2003) (98)
- Ocular manifestations of graft-v-host disease. (1983) (98)
- Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation (2003) (98)
- Esophageal abnormalities in chronic graft-versus-host disease in humans (1981) (97)
- Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. (1986) (93)
- Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia (1998) (91)
- Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. (2012) (90)
- Previous donor pregnancy as a risk factor for acute graft‐versus‐host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation (1990) (90)
- Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase (1998) (90)
- Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. (1986) (89)
- Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. (1987) (87)
- Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. (1992) (86)
- Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease. (2016) (85)
- DISORDERED SALIVARY IMMUNOGLOBULIN SECRETION AND SODIUM TRANSPORT IN HUMAN CHRONIC GRAFT‐VERSUS-HOST DISEASE (1983) (85)
- Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. (2010) (84)
- Self-administration of morphine in bone marrow transplant patients reduces drug requirement (1990) (83)
- Avascular necrosis following bone marrow transplantation: a case-control study. (1998) (83)
- Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. (1984) (83)
- The pathophysiology and treatment of graft-versus-host disease. (1983) (83)
- Gynecologic Manifestations of Chronic Graft-Versus-Host Disease (1982) (82)
- Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. (1985) (82)
- Recognition, incidence, and management of oral graft-versus-host disease. (1990) (81)
- Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. (1988) (80)
- Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. (2003) (80)
- Marrow transplantation for thalassemia. (1985) (78)
- Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. (2002) (78)
- Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. (1985) (77)
- Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. (1982) (76)
- Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita (1996) (76)
- HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. (1988) (75)
- Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial (2013) (73)
- Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. (1997) (72)
- Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. (1985) (72)
- Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. (2006) (72)
- Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. (2010) (70)
- Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease. (1985) (69)
- Intestinal and hepatic complications of human bone marrow transplantation. Part II. (1986) (68)
- MYCOBACTERIAL INFECTIONS IN MARROW TRANSPLANT PATIENTS (1983) (68)
- Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. (1998) (67)
- RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING: Influence of Time Postgrafting and Acute Graft‐Versus‐Host Disease (1984) (66)
- Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. (1982) (66)
- Graft‐vs.‐Host Disease (2007) (66)
- Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease (2009) (66)
- Myasthenia gravis after allogeneic bone marrow transplantation (1986) (65)
- Gynecological abnormalities following allogeneic bone marrow transplantation. (1990) (64)
- Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. (2019) (61)
- Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). (2004) (61)
- Allogeneic marrow transplantation. (1984) (61)
- Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. (1989) (60)
- Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. (2012) (60)
- Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. (1992) (59)
- Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. (1996) (59)
- Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial (2016) (58)
- Second marrow infusion for poor graft function after allogeneic marrow transplantation. (1986) (58)
- TREATMENT OF ACUTE GRAFT‐VERSUS‐HOST DISEASE WITH A NONMITOGENIC ANTI‐CD3 MONOCLONAL ANTIBODY (1992) (58)
- Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. (1982) (56)
- Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse. (1982) (56)
- How I treat refractory chronic graft-versus-host disease. (2019) (56)
- Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. (1992) (56)
- Radiographic features of esophageal involvement in chronic graft-vs.-host disease. (1984) (56)
- Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation (1996) (55)
- Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. (2004) (55)
- Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities (2000) (55)
- Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. (2007) (54)
- Growth and development in children after bone marrow transplantation. (1988) (54)
- The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. (1987) (54)
- Early and late interstitial pneumonia following human bone marrow transplantation. (1986) (53)
- Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. (1992) (53)
- Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. (1989) (53)
- Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation (1996) (52)
- A PHASE I‐II STUDY EVALUATING THE MURINE ANTI‐IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE (1990) (52)
- Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. (1982) (50)
- Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. (1996) (49)
- Head and Neck Complications of Bone Marrow Transplantation (1986) (49)
- Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study (2019) (49)
- Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease. (1984) (48)
- Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases (2017) (47)
- Physician Participation in Research Surveys (1999) (47)
- Allogeneic marrow transplantation for acute leukemia in relapse. (1982) (47)
- The management of chronic graft-versus-host disease. (1994) (46)
- Immunoglobulin therapy in bone marrow transplantation. (1987) (46)
- Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors. (1994) (46)
- Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. (1997) (46)
- Fanconi's anemia treated by allogeneic marrow transplantation. (1983) (45)
- Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment (2013) (45)
- Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. (2018) (44)
- Long‐term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond‐Blackfan syndrome) (1993) (43)
- A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. (1995) (43)
- Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. (1983) (43)
- Bone marrow transplantation for non-malignant disease. (2002) (43)
- Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. (2007) (43)
- Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. (1987) (42)
- Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. (1987) (42)
- Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures (2019) (41)
- High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. (1989) (40)
- The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. (1997) (40)
- Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration (2012) (39)
- Esophageal abnormalities in chronic graft-versus-host disease in humans. (1981) (39)
- Bone marrow transplantation for sickle cell disease. The United States experience. (1994) (37)
- Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. (1982) (37)
- A pilot study of low‐dose cyclosporin for graft‐versus‐host prophylaxis in marrow transplantation (1992) (36)
- Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience * (1989) (36)
- Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. (1998) (36)
- Current and Future Preparative Regimens for Bone Marrow Transplantation in Thalassemia a (1998) (36)
- Roles for Agent Technology in Knowledge Management: Examples from Applications in Aerospace and Medicine (1997) (35)
- What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? (1990) (35)
- Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. (1992) (35)
- Bone marrow transplantation for thalassemia. The USA experience. (1994) (35)
- Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva. (1985) (34)
- Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease. (1987) (34)
- Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine? (1997) (34)
- Cyclophosphamide‐based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma (2015) (33)
- Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. (1991) (33)
- Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. (2010) (32)
- Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma. (2017) (32)
- Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection (2008) (32)
- Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors (2012) (32)
- Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. (1999) (31)
- Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. (1994) (30)
- Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. (1991) (30)
- Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. (1985) (29)
- Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts. (1988) (29)
- Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. (1997) (29)
- Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization. (2017) (29)
- Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. (1988) (29)
- Marrow transplant experience for children with severe aplastic anemia. (1994) (28)
- Marrow transplantation in hepatitis‐associated aplastic anemia (1984) (28)
- An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial (2018) (27)
- Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study. (1983) (26)
- Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? (2009) (26)
- Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement (2016) (26)
- Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft‐versus‐host disease (1996) (26)
- Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. (1983) (25)
- The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients. (1983) (25)
- Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial. (2011) (25)
- Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation (2011) (25)
- Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial (1997) (23)
- Low serum thymic hormone levels in patients with chronic graft-versus-host disease (1982) (21)
- Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT). (2019) (21)
- Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery (2016) (21)
- Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories. (1989) (21)
- Generating Practice Cases for Medical Training from a Knowledge-Based Decision-Support System (2002) (21)
- Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3–6/6 HLA matched donors (2009) (20)
- Oral Complications of Bone-Marrow Transplantation (1983) (20)
- Machine learning predicts stem cell transplant response in severe scleroderma (2020) (19)
- Cell-Based Therapies (2012) (19)
- The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review (2016) (19)
- A Clinical Review: Cutaneous Manifestations of Acute and Chronic Graft‐versus‐Host Disease Following Bone Marrow Transplantation (1991) (18)
- Stem-cell transplantation for sickle cell disease. (2010) (18)
- Direct ultrastructural evidence of target-directed polarization by cytotoxic lymphocytes in lesions of human graft-vs-host disease. (1987) (18)
- CARE-PARTNER: a computerized knowledge-support system for stem-cell post-transplant long-term follow-up on the World-Wide-Web (1998) (18)
- Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. (2011) (18)
- Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. (1986) (17)
- Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation. (1992) (17)
- Bone Marrow Transplantation for NonMalignant Disease (2000) (17)
- Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. (1997) (17)
- Spontaneous factor VIII inhibitor occurring in association with chronic graft‐versus‐host disease (1994) (17)
- Integrating Case-Based Reasoning, Rule-Based Reasoning and Intelligent Information Retrieval for Medical Problem-Solving (1998) (17)
- Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors. (1996) (17)
- Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. (1998) (17)
- Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders (1997) (17)
- Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma (2011) (17)
- Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. (1997) (16)
- Pharmacologic Prevention of Acute Graft‐Versus‐Host Disease (2009) (16)
- Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors (1988) (15)
- Longterm followup and quality of life after hematopoietic stem cell transplantation. (1997) (15)
- Efficacy and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients 18 Years of Age or Older: First Results of the Phase 3 Randomized, Placebo-Controlled ZOE-HSCT Clinical Trial (2018) (15)
- Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. (1992) (14)
- Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia (1989) (14)
- Long-term results of allogeneic bone marrow transplantation. (1989) (14)
- Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. (2014) (14)
- Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas (1978) (14)
- Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation. (1986) (13)
- Introduction to a symposium on sickle cell anemia: current results of comprehensive care and the evolving role of bone marrow transplantation. (1991) (13)
- Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice (2021) (13)
- KS-3000 : An Application of DDUCKS to Bone-Marrow Transplant Patient Support (1992) (13)
- Autologous Marrow Transplantation for Malignant Lymphoma (1986) (13)
- Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up. (1988) (13)
- Donor buffy coat cell infusion after marrow transplantation for aplastic anemia. (1988) (13)
- Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation. (1982) (12)
- Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation. (1990) (12)
- Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults. (2015) (12)
- Two cases of transfusion-associated graft-vs-host disease after open heart surgery. (1992) (11)
- Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia (1990) (11)
- Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. (1991) (10)
- High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma (2018) (10)
- Intravenous immune globulin prophylaxis in recipients of a marrow transplant. (1989) (10)
- Case Based Reasoning for Medical Decision-Support in a Safety Critical Environment (2003) (10)
- Reasoning from Knowledge Supported by More or Less Evidence in a Computerized Decision Support System for Bone-Marrow Post- Transplant Care (1998) (9)
- Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis (2020) (9)
- Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease. (2018) (9)
- Application of stem cell transplantation to autoimmune diseases. (2019) (9)
- Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE) (2015) (9)
- Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation (2020) (8)
- Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation. (1989) (8)
- "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. (2010) (8)
- Bacterial, Fungal, and Protozoan Infection After Marrow Transplantation (1988) (8)
- A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants. (1995) (8)
- Myeloablative Autologous Transplantation of CD34 + Selected Hematopoietic Stem Cells (HSCT) vs Monthly Intravenous Cyclophosphamide (CY) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial (2017) (8)
- Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months. (1989) (8)
- Effects of treatment regimens on post marrow transplant relapse. (1991) (8)
- Quantifying skin stiffness in graft-versus-host disease, morphea and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography. (2020) (7)
- Treatment of marrow graft recipients with thymopentin. (1987) (7)
- Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case. (1986) (7)
- Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma (2011) (7)
- Congress review: progress and prospects in bone marrow transplantation. (1989) (7)
- Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation. (1991) (7)
- Complications of allogeneic bone marrow transplantation. (1994) (7)
- High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward. (2004) (7)
- Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. (2017) (7)
- Haemopoietic stem-cell transplantation for systemic sclerosis (2012) (7)
- Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation (2013) (7)
- Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning. (2017) (6)
- A Phase I/II trial of weekly gemcitabine with celecoxib and thalidomide for patients with advanced pancreatic cancer (2005) (5)
- Obstructive Lung Disease after Allogeneic Marrow Transplantation (2020) (5)
- Supportive care of the marrow transplant recipient: the Seattle Experience. (1990) (5)
- Current status of bone marrow transplantation. (1989) (5)
- Hematopoietic Cell Transplantation for Sickle Cell Disease: Updated Results of the Multicenter Trial. (2004) (5)
- One day preparative regimen for allogeneic non-myeloablative stem cell transplantation using 3-5/6 HLA matched related donors (2003) (5)
- Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis (2009) (5)
- Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia. (1992) (5)
- Gastric antral vascular ectasia (GAVE) in early diffuse SSc: Report from the SCOT trial (2008) (4)
- Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry (2011) (4)
- Managing Personnel through Staff Scheduling Algorithms (1999) (4)
- One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster Virus (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic Cell Transplant (HCT) Recipients (2013) (4)
- Body weight and outcome of hematopoietic stem cell transplantation. (1998) (4)
- Allogeneic HSCT for autoimmune disease: a shared decision (2019) (4)
- Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan. (1993) (4)
- Long-term complications of bone marrow transplantation. (1989) (4)
- Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease. (2018) (4)
- High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease (2019) (3)
- Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease. (2019) (3)
- Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis. (2006) (3)
- Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literature (2021) (3)
- Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors (2011) (3)
- Antithymocyte globulin followed by cyclosporine for the treatment of acute GVHD in patients given HLA-identical or -nonidentical marrow grafts (1986) (3)
- Chronic graft-versus-host disease. (1990) (3)
- Graft-versus-host reactions: anti-leukemia effects of donor T cells. (1996) (3)
- Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation. (2000) (3)
- Cross-trial comparisons in reviews: proceed with caution (2020) (3)
- Marrow transplantation for malignant plasma cell disorders (1989) (3)
- Bone marrow transplantation for non-malignant disease (2000) (3)
- High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs. (2004) (3)
- High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation (2011) (3)
- Safety and efficacy of HSCT for systemic sclerosis across clinical trials (2020) (3)
- Efficacy and safety of high‐dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma (2017) (3)
- Plerixafor Given “Just In Time” For Peripheral Blood Stem Cell Mobilization Of Patients With Suboptimal Response To G-CSF (2010) (2)
- Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. (2022) (2)
- Denials Of Treatment Coverage By Health Insurance Carriers Restrict Patient Recruitment On A Randomized Clinical Trial: Experience Of 95 Patients With Systemic Sclerosis (SSc) Enrolled In The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) Trial (2010) (2)
- Predictive facts and prevention of acute graft-versus-host disease (1988) (2)
- Phase I, Dose Escalation Study of Naïve T-Cell Depleted Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation (2019) (2)
- Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality (2020) (2)
- Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis (2022) (2)
- Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic Leukemia (2020) (2)
- Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors. (2005) (2)
- Cognitive-behavioral training to reduce chemokadiotherapy toxicities (1984) (2)
- Cyclophosphamide in scleroderma lung disease. (2006) (2)
- Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. (2018) (2)
- Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data (2021) (2)
- Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation (2013) (2)
- Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes. (2020) (2)
- Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival. (2006) (2)
- Infections Post Transplant Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation (2003) (2)
- Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation. (1987) (1)
- Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation (2020) (1)
- Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin. (1996) (1)
- Medical expert systems (2004) (1)
- Chimeras - no longer a myth. (1983) (1)
- Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? (1983) (1)
- Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. (2022) (1)
- Immunosuppressive agents for prevention of graft-versus-host disease (1995) (1)
- Enrollment Lessons from a Biologic Assignment Study of Marrow Transplantation vs Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. (2022) (1)
- Late Effects of Hematopoietic Stem Cell Transplantation (2000) (1)
- Hematopoietic Stem Cell Transplantation at Home (2017) (1)
- Fain following intensive chemoradiotherapy and bone marrow transplantation (EMT) (1984) (1)
- Polymerase chain reaction—technology and applications (1991) (1)
- Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning (2016) (1)
- Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle (1988) (1)
- Autologous Stem-Cell Transplantation for Severe Scleroderma. (2018) (1)
- Marrow Transplantation for Severe Aplastic Anemia (2020) (1)
- Distributed Reuse of Knowledge in a Computerized Decision Support System for Bone-Marrow Post-Transplant Care Over the World Wide Web (1997) (1)
- 244: Fludarabine-based non-myeloablative stem cell transplantation in a patient with sickle cell disease and renal failure: Clinical outcome and pharmacokinetic comparison to patients with normal renal function (2007) (1)
- Oral pain resulting from chemoradiotherapy in a bone marrow transplant setting (1987) (1)
- 78: Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease Among 30-Year Survivors of Bone Marrow Transplant (2008) (1)
- Long Term Survival Following High Dose Sequential Chemotherapy With Autologous Hematopoietic Cell Rescue For Multiple Myeloma (2010) (1)
- EPR22-118: Incidence of Herpes Zoster in Immunocompromised Individuals and Zoster Vaccination as an Effective Preventative Strategy (2022) (0)
- CLO20-049: Retrospective Study of Safety and Toxicity Profile Comparison for Propylene Glycol-Free Melphalan (Evomela®) and Generic Melphalan (2020) (0)
- Atypical Myeloproliferative Disorder : Further Analysis of the ZNF 198 Gene and Lack of Evidence for Multiple Genes Disrupted on Chromosome 13 (1998) (0)
- Reconstitution of immunity after autologous CD34 cell transplantation for autoimmune diseases (2004) (0)
- Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma. (2008) (0)
- Total Body Irradiation 1350cGy/Fludarabine (TBI/FLU) vs Myeloablative Busulfan/Fludarabine (Bu/Flu) Preparation in Adult Recipients of Dual Umbilical Cord Blood (UCB) Transplantation: Superior Engraftment with Low Treatment-Related Mortality (2008) (0)
- Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia (2003) (0)
- Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality (2019) (0)
- 611 A novel method of objectively quantifying cutaneous sclerosis (2018) (0)
- International symposium on hematopoietic stem cell transplantation for autoimmune diseases (1997) (0)
- Efficacy of Autologous Stem Cell Transplantation in Older Multiple Myeloma Patients (2016) (0)
- Editorial: Stem cell transplantation in autoimmune diseases (AID) (2023) (0)
- Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation (2023) (0)
- T AIIogeneic Marrow Transplantation Randomized Study Comparing Corticosteroids and Cyclosporine (1985) (0)
- Improving outcomes in scleroderma: recent progress of cell-based therapies. (2022) (0)
- S.1.1 Organ function and quality of life correlates at randomization on the SCOT (Scleroderma: Cyclophosphamide Or Transplantion) Trial (2012) (0)
- Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma. (2008) (0)
- New M alignant D iseases A fter A llogeneic M arrow Transplantation f or C hildhood A cute L eukemia (2000) (0)
- Supportive care of the marrow transplant recipient (1990) (0)
- NiCord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation (2012) (0)
- Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors (2006) (0)
- Pre-transplant marital status and hematopoietic cell transplantation outcomes. (2020) (0)
- Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis (2011) (0)
- Organ Function and Quality of Life Correlates at Randomization on the Scot (Scleroderma: Cyclophosphamide or Transplantation) Trial (2011) (0)
- Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation (2012) (0)
- Graft-versus-host reactions (1996) (0)
- Outcomes of a 1-Day Nonmyeloablative Preparative Regimen for Primary Graft Failure After Allogeneic Stem Cell Transplantation (2011) (0)
- A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503 (2019) (0)
- Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial (2015) (0)
- Classic Papers and Current Comments Highlights of Leukemia Research (2002) (0)
- Graft-Versus-Host Disease: A Prospective, Randomized Trial Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of (2011) (0)
- Unique immunologic problems in human bone marrow transplant recipients. (1981) (0)
- Antithymocyte Globulin Aplastic Anemia Conditioned by Cyclophosphamide Combined With Long-Term Follow-Up of Allogeneic Marrow Transplants in Patients With (2011) (0)
- Results of allogeneic marrow transplantation in patients transplanted for leukemia: A five year follow-up (1986) (0)
- disease in patients undergoing marrow transplants? What role for prednisone in prevention of acute graft-versus-host (2011) (0)
- Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc). (2006) (0)
- bone marrow transplantation Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic (2011) (0)
- The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation, (2011) (0)
- TU‐EE‐A2‐05: Challenges in Limiting Kidney Dose When Delivering Total Body Irradiation (TBI) for Patients with Severe Systemic Sclerosis (SSc) (2007) (0)
- transplantation chronic graft-versus-host disease after allogeneic bone marrow Value of day 100 screening studies for predicting the development of (2011) (0)
- Clinical and Neuroimaging Correlates of Post-Transplant Delirium. (2020) (0)
- Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases) (2005) (0)
- Data from: Quantifying skin stiffness in graft-versus-host disease, morphea and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography (2020) (0)
- Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia. (1990) (0)
- Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies. (2010) (0)
- Secure JAVA Applets and Applications: Guidelines and Lessons Learnt from the JAVA Security Model (1999) (0)
- 7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies? (2020) (0)
- Reduction intransplant-relat ed complications inpatients given intravenous immuneglobulin after allogeneic marrow transplantation (1994) (0)
- Marrow transplantation for disorders of hematopoiesis. (1993) (0)
- POLYMERASE CHAIN REACTION (1991) (0)
- Chromosome-Positive Acute Lymphoblastic Leukemia Marrow Transplants From Unrelated Donors for Treatment of Philadelphia (2011) (0)
- Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation. (2005) (0)
- A Phase 1 Study of the Safety and Feasibility of Improving Cardiorespiratory Fitness through a Remotely Monitored, Mobile Health Supported High Intensity Interval Training Program (REMM-HIIT) (2021) (0)
- the US multicenter pilot study of cell transplantation for severe systemic sclerosis: long-term follow-up High-dose immunosuppressive therapy and autologous hematopoietic (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Keith M. Sullivan?
Keith M. Sullivan is affiliated with the following schools:
